Study of JTX-8064, as Monotherapy and in Combination With a PD-1 Inhibitor, in Adult Subjects With Advanced Refractory Solid Tumors

Weill Cornell, New York

Mount Sinai, New York

Montefiore Medical Center PRIME, New York

Fox Chase Cancer Center, Philadelphia

Georgetown University, Washington D.C.

Carolina BioOncology, Huntersville

Prisma Health, Greenville

Augusta Oncology Associates - Wheeler Road, Augusta

University of Florida, Gainesville

Adventist Health System/Sunbelt, Inc., Orlando

University of Miami - Sylvester Comprehensive Cancer Center, Miami

Tampa General Hospital, Tampa

University of Alabama at Birmingham, Birmingham

University of Kentucky Chandler Medical Center (UKCMC), Lexington

Case Comprehensive Cancer Center, Cleveland

Gabrail Cancer Center, Canton

UC Health, LLC, Cincinnati

University of Michigan, Ann Arbor

Barbara Ann Karmanos Cancer Center, Detroit

Henry Ford Hospital, Detroit

START Midwest -Cancer & Hematology Center of Western Michigan, Grand Rapids

Medical College of Wisconsin, Milwaukee

The Board of Regents of the University of Wisconsin, Madison

Regents of the University of Minnesota, Minneapolis

University of Chicago, Chicago

Cancer Care Center of Decatur, Decatur

University of Arkansas Medical Sciences, Little Rock

University of Oklahoma Health Sciences Center, Oklahoma City

Mary Crowley Cancer Research, Dallas

Oncology Consultants, P.A., Houston

MD Anderson, Houston

START Texas Accelerated Research Therapeutics, San Antonio

Joe Arrington Cancer Research & Treatment Center, Lubbock

START Mountain Region, West Valley City

Banner MD Anderson Cancer Center, Gilbert

Arizona Clinical Research Center, Tucson

Cedars Sinai, Los Angeles

City of Hope, Duarte

California Cancer Associates for Research & Excellence, Inc., La Jolla

University of California, San Diego, La Jolla

UC Irvine Medical Center, Orange

University of California, Davis, Sacramento

Providence Portland Cancer Center, Portland

Seattle Cancer Care Alliance, Seattle

Yale University, New Haven